Ignite Creation Date:
2024-05-05 @ 10:31 PM
Last Modification Date:
2024-10-26 @ 10:20 AM
Study NCT ID:
NCT01126554
Status:
COMPLETED
Last Update Posted:
2014-04-29
First Post:
2010-05-17
Brief Title:
ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill Patients
Sponsor:
University of Zurich
Organization:
University of Zurich
Study Overview
Official Title:
ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill
Status:
COMPLETED
Status Verified Date:
2014-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Greenpep
Brief Summary:
Comparison of ICG liver testing with copeptin and SAPS II score as prognostic markers in critically ill patients
Detailed Description:
Comparison of different marker for length of stay in the ICU in critically ill patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CIM_02 | OTHER | KEK | None |